Expanding the IP protection of biologics

Protection of a family of biologics : The combination of all interesting mutation positions of a protein sequence is achieved. The combinations that improve the performance of the molecules are all identified and protected, thus reducing the risks of patent loopholes and the emergence of competing molecules.